Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion